ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1346 • 2016 ACR/ARHP Annual Meeting

    Factors That Influence Therapy in Patients with Undifferentiated Connective Tissue Disease

    Diana P. Pena1 and Anca D. Askanase2, 1Rheumatology, Universidad Militar Nueva Granada, Bogotá, Colombia, 2Department of Medicine, Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY

    Background/Purpose: To compare clinical and immunological characteristics in patients with undifferentiated connective tissue disease (UCTD) treated with hydroxycholoroquine (HCQ) in a large academic clinical practice.…
  • Abstract Number: 1347 • 2016 ACR/ARHP Annual Meeting

    Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Characteristics, Treatment and Outcome in 251 Cases from the Literature

    Charlotte Laurent1, Jean Capron2, Sonia Alamowitch3, Bluenn Quillerou4, Guy Thomas4, Olivier Fain5 and Arsène Mékinian5, 1Internal Medicine, Internal Medicine, Hôpital Saint-Antoine, Paris, paris, France, 2Neurology, Neurology, Hôpital Saint-Antoine, paris, France, 3Neurology, Neurology - Hopital St Antoine, paris, France, 4Psychiatry, Psychiatry Hopital St Antoine, paris, France, 5Service de médecine interne. Hôpital Saint-Antoine., Paris, France

    Background/Purpose: Steroid-responsive encephalopathy and associated autoimmune thyroiditis (SREAT) is characterized by encephalopathy and the presence of antithyroid antibodies. We describe the clinical presentation, outcome and…
  • Abstract Number: 1348 • 2016 ACR/ARHP Annual Meeting

    Neuromyelitis Optica: Patient Characteristics and Treatment Patterns Among Rheumatologists Versus Non-Rheumatologists

    Sabrina Gmuca1, Rui Xiao2, Amy T. Waldman3, Jeffrey S. Gerber4 and Pamela F. Weiss5, 1Pediatric Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA, 2Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 3Pediatric Neurology, The Children's Hospital of Philadelphia, Philadelphia, PA, 4The Children's Hospital of Philadelphia, Philadelphia, PA, 5Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Neuromyelitis optica (NMO) is an immune-mediated inflammatory disorder of the central nervous system that has been associated with systemic autoimmunity often cared for by…
  • Abstract Number: 1349 • 2016 ACR/ARHP Annual Meeting

    Clinical Analysis of Hypertrophic Pachymeningitis

    Risa Wakiya, Atsushi Kondo, Hiroki Ozaki, Hiromi Shimada, Shusaku Nakashima, Miharu Izumikawa, Tomohiro Kameda and Hiroaki Dobashi, Internal Medicine Division of Hematology, Rheumatology, and Respiratory Medicine, Kagawa University, Kagawa, Japan

    Background/Purpose:  Hypertrophic pachymeningitis (HP) is a rare, chronic and inflammatory disorder. HP is characterized by thickening of the cranial dura mater. The cause of HP…
  • Abstract Number: 1350 • 2016 ACR/ARHP Annual Meeting

    Asymptomatic Coccidioidomycosis in Patients with Rheumatic Disease: 8 Years of Experience

    Usman Ajaz1, Jeffrey R. Lisse2, Neil M. Ampel3 and Dominick Sudano4, 1Department of Medicine, University of Arizona, Tucson, AZ, 2Arizona Arthritis Center, University of Arizona, Tucson, AZ, 3Department of Infectious Disease, Southern AZ VA Medical Center, Tucson, AZ, 4Department of Rheumatology, University of Arizona, Tucson, AZ

    Background/Purpose: Coccidioidomycosis (valley fever) is an endemic fungal infection that typically causes a self-limited pulmonary illness in the Southwestern United States,. Immunosuppressed patients are at…
  • Abstract Number: 1351 • 2016 ACR/ARHP Annual Meeting

    Mortality and Prognostic Factors of Pneumocystis Pneumonia in Patients with Connective Tissue Diseases

    Mitsuhiro Akiyama1, Yuko Kaneko2 and Tsutomu Takeuchi2, 1Division of Rheumatology, Department of Internal Medicine,, Keio University School of Medicine, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose:  Pneumocystis pneumonia (PCP) is one of the severe opportunistic infections in immunocompromised patients. PCP is still a leading cause of death in patients with…
  • Abstract Number: 1352 • 2016 ACR/ARHP Annual Meeting

    Predictors of Mortality in Rheumatic Disease Patients with CMV Infection

    Kyoung Yong Lee1, Seung Min Jung1, Sang-Won Lee2, Yong-Beom Park2 and Jason Jungsik Song2, 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

    Background/Purpose: Immunosuppressive therapy, which is frequently used to treat various rheumatic diseases, increases risk of opportunistic infection. However, few reports were available on the prognosis…
  • Abstract Number: 1353 • 2016 ACR/ARHP Annual Meeting

    Risk Factors of Pulmonary Mycobacterium Avium-Comlex (MAC) Disease and the Significance of Anti-MAC Antibody in Patients with Rheumatic Diseases

    Tamao Nakashita1, Shinji Motojima2, Akira Jibatake2, Akira Yoshida2 and Yoshiki Yamamoto2, 1Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa-city, Japan, 2Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa city, Japan

    Background/Purpose: Pulmonary MAC disease is caused by MAC and the incidence is increasing in Japan. It is also becoming a great concern in the field…
  • Abstract Number: 1354 • 2016 ACR/ARHP Annual Meeting

    Ultrasound Verified Inflammation and Structural Abnormalities in Patients with Hemochromatosis with and without Associated Arthropathy

    Christian Dejaco1, Andreas Stadlmayr2, Viktoria Trimmel3, Christina Duftner4, Rusmir Husic1, Elisabeth Krones5, Shahin Zhandieh6, Emma Husar-Memmer7, Gernot Zollner8, Josef Hermann1, Judith Gretler1, Angelika Lackner1, Anja Ficjan1, Christian Datz2, Roland Axmann7 and Jochen Zwerina9, 1Rheumatology and Immunology, Medical University Graz, Graz, Austria, 2Internal Medicine, General Hospital Oberndorf, Oberndorf, Austria, 3Radiology, Medical University Graz, Graz, Austria, 4Medical University Innsbruck, Innsbruck, Austria, 5Gastroenterology and Hepatology, Medical University Graz, Graz, Austria, 6Radiology, Hanusch Hospital, Vienna, Austria, 7First Department of Internal Medicine, Hanusch Hospital, Vienna, Austria, 8Gastroenterology, Medical University Graz, Graz, Austria, 9First Department of Internal Medicine and Ludwig Bolzmann Institute of Osteology, Hanusch Hospital, Vienna, Austria

    Background/Purpose:  To study inflammatory and structural ultrasound lesions in patients with hereditary hemochromatosis (HH) with and without arthropathy Methods:   Cross-sectional study of 50 patients…
  • Abstract Number: 1355 • 2016 ACR/ARHP Annual Meeting

    ASAH1 Gene Mutations Cause Acid Ceramidase Deficiency (Farber Disease), with Symptoms Including Arthritis and Subcutaneous Nodules. Patients Are Often Misdiagnosed with JIA, and Slowly Progressive Disease May Only be Diagnosed in Adulthood

    Alexander Solyom1, Calogera Simonaro2 and Edward Schuchman3, 1Roivant Sciences, New York, NY, 2Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 3Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Mutations in the ASAH1 gene cause acid ceramidase deficiency, accumulation of the pro-inflammatory and pro-apoptotic lipid ceramide, and a distinct set of clinical features,…
  • Abstract Number: 1356 • 2016 ACR/ARHP Annual Meeting

    Correlation of Erythrocyte Sedimentation Rate with Glycohemoglobin Values and Other Patient Factors

    Brian LaMoreaux, Dept of Internal Medicine, Division of Rheumatology, The Ohio State University, Columbus, OH

    Background/Purpose: The erythrocyte sedimentation rate (ESR) is a laboratory test commonly used in clinical practice as an assessment of systemic inflammation. The glycohemoglobin (A1c) measures…
  • Abstract Number: 1357 • 2016 ACR/ARHP Annual Meeting

    Clinical Description of Patients with Cytoplasmic Discrete Speckles on Indirect Immunofluorescence on HEp-2 Cells in a Universitary Hospital

    Martin Brom1, Carolina Eva Carrizo2, Roberto Arana3 and Cecilia N. Pisoni3, 1Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2CEMIC, Buenos Aires, Argentina, 3Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina

    Background/Purpose: Indirect Immunofluorescence (IIF) shows different nuclear and cytoplasmic fluorescence patterns depending on the antibodies present in the cell. Cytoplasmic patterns are an unusual finding.…
  • Abstract Number: 1358 • 2016 ACR/ARHP Annual Meeting

    Response of Hidradenitis Suppurativa to Biologic Therapy

    Shaunak Mulani1, Sean McNish2, Sarah Harris1 and Victoria K. Shanmugam2, 1The George Washington University, Washington, DC, 2Division of Rheumatology, The George Washington University, Washington, DC

    Response of Hidradenitis Suppurativa to Biologic Therapy Background/Purpose: Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory disease of apocrine sweat glands, characterized by recurrent abscessing…
  • Abstract Number: 1359 • 2016 ACR/ARHP Annual Meeting

    New Markers for Celiac Disease: Anti-Neo-Epitope Human and Microbial Transglutaminases

    Torsten Matthias1, Sandra Neidhöfer2, Patricia Jeremias1 and Aaron Lerner3, 1Aesku.Kipp.Institute, Wendelsheim, Germany, 2AESKU.KIPP.Stitute, Wendelsheim, Germany, 3B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

    Background/Purpose: Microbial transglutaminase (mTg) and human tissue Tg (tTg) complexed to gliadin peptides present neo-epitopes. Antibodies against these complexes are called tTg neo-epitope and mTg…
  • Abstract Number: 1360 • 2016 ACR/ARHP Annual Meeting

    Discontinuation Causes of Biological Therapies: Over a Five-Year Period. Biobadasar

    Diego Baenas1, Soledad Retamozo2, Alejandro Alvarellos2, Francisco Caeiro3, Maria Jezabel Haye Salinas1, Juan Pablo Pirola3, María Celina de La Vega4, Gustavo Casado5, Gimena Gomez6, Javier Roberti7, Osvaldo Luis Cerda8, Ignacio Javier Gandino9, Ana Quinteros10, Ida Exeni5,11, Belen Barrios12, Carla Gobbi13, Analia Alvarez14, Amelia Granel15, Alejandra Peluzzon16, Ana Capuccio17, Romina Nieto18, Rossana Quintana19,20, Eduardo Mussano21,22, Santiago Scarafia23, Mercedes Argentina García24, Mercedes De La Sota25, Karin Kirmayr26, Edson Javier Velozo27, Santiago Aguero28, Cristina Battagliotti29, Sidney Soares de Souza30, Emilia Cavillon31, Analia Bohr32, Andrea Smichowski33, Alejandro Benitez34, Daniela Vidal35, Dora Pereira36, Liliana Martinez37, Luis Somma38, Marta Zalazar39, Pablo Finucci Curi40, Leandro Carlevaris41, Guillermo Berbotto42 and Veronica Saurit43, 1Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 2Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Postgraduate Career of Rheumatology Catholic University of Córdoba, Fundación para las Ciencias Biomédicas de Córdoba (FUCIBICO), Cordoba, Argentina, 3Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, 4Sociedad Argentina de Reumatología, CABA, Argentina, 5Sociedad Argentina de Reumatologia, CABA, Argentina, 6Sociedad Argentina de Reumatología, Buenos Aires, Argentina, 7SAR, CABA, Argentina, 8Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 9Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 10Centro Integral Reumatológico, Tucuman, Argentina, 11Sanatorio Parque, Cordoba, Argentina, 12Hospital Tornu, CABA, Argentina, 13Rheumatology, Sanatorio Allende de Córdoba, Cordoba, Argentina, 14Hospital Penna, Bahía Blanca, Argentina, 15Centro Platense de Reumatología, La Plata, Argentina, 16Hospital Clínica José de San Martín, CABA, Argentina, 17Hospital Cesar Milstein, CABA, Argentina, 18Hospital Provincial, Rosario, Argentina, 19Sanatorio Parque, Rosario, Argentina, 20SAR, Rosario, Argentina, 21Córdoba, Hospital Nacional de Clínicas, Córdoba, Argentina, 22SAR, Cordoba, Argentina, 23Hospital Bernardino Rivadavia, CABA, Argentina, 24Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, 25Consultorios, Bahia Blanca, Argentina, 26Sociedad Argentina de Reumatologia. Argentina, CABA, Argentina, 27Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina, 28Sanatorio Pasteur, Catamarca, Argentina, 29Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, 30Ramallo 1851, REUMAR, CABA, Argentina, 31Consultorio, Cordoba, Argentina, 32Hospital de Rehabilitación Rocca, CABA, Argentina, 33Atención Integral de Reumatología, CABA, Argentina, 34CEIM, CABA, Argentina, 35Hospital de Niños de Córdoba, Córdoba, Argentina, 36Centro Raquis, Buenos Aires, Argentina, 37Hospital Fernandez, CABA, Argentina, 38SOMMA, Buenos Aires, Argentina, 39Hospital Pirovano, CABA, Argentina, 40Centro Médico Mitre, Entre Rios, Argentina, 41IARI, CABA, Argentina, 42Sanatorio Británico, Rosario, Argentina, 43Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina

    Background/Purpose: To analyze discontinuation causes of biologics therapies (bDMARDs) in patients who are registered in the database BIOBADASAR. Methods: Database included demographics of patients, type…
  • « Previous Page
  • 1
  • …
  • 1687
  • 1688
  • 1689
  • 1690
  • 1691
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology